Lea C. Rodriguez
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Low-penetrance TP53 variants are mainly hypomorphic: an underestimated issue with high clinical significance.
Journal: NPJ genomic medicine
Published: September 20, 2025
Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors.
Journal: Brain, behavior, and immunity
Published: April 09, 2024
TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4.
Journal: Neuron
Published: June 21, 2022
B cell-dependent EAE induces visual deficits in the mouse with similarities to human autoimmune demyelinating diseases.
Journal: Journal of neuroinflammation
Published: November 26, 2021
Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells.
Journal: International journal of molecular sciences
Published: September 28, 2021
The Lack of Amyloidogenic Activity Is Persistent in Old WT and APPswe/PS1ΔE9 Mouse Retinae.
Journal: International journal of molecular sciences
Published: September 15, 2021
Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies.
Journal: Neurobiology of disease
Published: December 07, 2020
Tau Gene Deletion does not Influence Axonal Regeneration and Retinal Neuron Survival in the Injured Mouse Visual System.
Journal: International journal of molecular sciences
Published: May 09, 2020
Tau modulates visual plasticity in adult and old mice.
Journal: Neurobiology of aging
Published: April 04, 2020
Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury.
Journal: Cell death & disease
Published: September 13, 2019
Last Updated: 09/26/2026